Clark D B, Drohan W N, Miekka S I, Katz A J
American Red Cross, Jerome H. Holland Laboratory, Biomedical Sciences, Rockville, MD 20855.
Ann Clin Lab Sci. 1989 May-Jun;19(3):196-207.
Advances in biotechnology are permitting significant changes in traditional plasma fractionation schemes. Increases in product purity, safety, and recovery are possible, and new products are being developed. Applications of technology to the purification of factor IX, factor X, protein C, antithrombin III, thrombin, and fibrin glue are described.
生物技术的进步使传统血浆分级分离方案发生了重大变化。提高产品纯度、安全性和回收率成为可能，并且正在开发新产品。本文描述了该技术在纯化凝血因子IX、凝血因子X、蛋白C、抗凝血酶III、凝血酶和纤维蛋白胶方面的应用。
